Schildkraut JM - Search Results

1

First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women.

Bethea TN, Ochs-Balcom HM, Bandera EV, Beeghly-Fadiel A, Camacho F, Chyn D, Cloyd EK, Harris HR, Joslin CE, Myers E, Moorman PG, Peres LC, Rosenow W, Setiawan VW, Wu AH, Rosenberg L, Schildkraut JM. Bethea TN, et al. Among authors: schildkraut jm. Int J Cancer. 2021 Jun 15;148(12):2964-2973. doi: 10.1002/ijc.33493. Epub 2021 Feb 17. Int J Cancer. 2021. PMID: 33521947 Free PMC article.

2

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Berry DA, et al. J Natl Cancer Inst. 1997 Feb 5;89(3):227-38. doi: 10.1093/jnci/89.3.227. J Natl Cancer Inst. 1997. PMID: 9017003

3

Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history.

Claus EB, Schildkraut J, Iversen ES Jr, Berry D, Parmigiani G. Claus EB, et al. J Natl Cancer Inst. 1998 Dec 2;90(23):1824-9. doi: 10.1093/jnci/90.23.1824. J Natl Cancer Inst. 1998. PMID: 9839523

4

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.

Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. Schildkraut JM, et al. J Natl Cancer Inst. 2002 Jan 2;94(1):32-8. doi: 10.1093/jnci/94.1.32. J Natl Cancer Inst. 2002. PMID: 11773280

5

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Moorman PG, et al. Among authors: schildkraut jm. Cancer Causes Control. 2002 Nov;13(9):807-11. doi: 10.1023/a:1020678100977. Cancer Causes Control. 2002. PMID: 12462545

6

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Among authors: schildkraut jm. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

7

Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.

Wenham RM, Schildkraut JM, McLean K, Calingaert B, Bentley RC, Marks J, Berchuck A. Wenham RM, et al. Among authors: schildkraut jm. Clin Cancer Res. 2003 Oct 1;9(12):4396-403. Clin Cancer Res. 2003. PMID: 14555511

8

Racial differences in enrolment in a cancer genetics registry.

Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM. Moorman PG, et al. Among authors: schildkraut jm. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1349-54. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298957

9

IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.

Schildkraut JM, Demark-Wahnefried W, Wenham RM, Grubber J, Jeffreys AS, Grambow SC, Marks JR, Moorman PG, Hoyo C, Ali S, Walther PJ. Schildkraut JM, et al. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):403-8. doi: 10.1158/1055-9965.EPI-04-0426. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734965

10

Antidepressant medication use [corrected] and risk of ovarian cancer.

Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Moorman PG, et al. Among authors: schildkraut jm. Obstet Gynecol. 2005 Apr;105(4):725-30. doi: 10.1097/01.AOG.0000157113.98061.eb. Obstet Gynecol. 2005. PMID: 15802397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters